Matteo Lambertini, MD

Articles by Matteo Lambertini, MD

SABCS 2024 Data Show ‘Great Steps Forward’ in Breast Cancer Care

ByPaolo Tarantino, MD, PhD,Matteo Lambertini, MD

January 13th 2025

Paolo Tarantino, MD, and Matteo Lambertini, MD, PhD discuss findings related to CDK4/6 inhibitors and antibody drug conjugates presented at SABCS 2024.

Preserving Fertility in BRCA-Positive Breast Cancer

ByMatteo Lambertini, MD

September 19th 2017

In this interview we discuss a recent study presented at ESMO on fertility-preserving procedures for women with BRCA-positive breast cancers

Latest Updated Articles

Preserving Fertility in BRCA-Positive Breast Cancer
September 19th 2017
SABCS 2024 Data Show ‘Great Steps Forward’ in Breast Cancer Care
January 13th 2025

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Achieving a “Functional Cure” With Multiple Myeloma Therapy

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)